Both in Pharmaceuticals
Atossa Therapeutics vs TherapeuticsMD
Over the past year ATOS returned −83.0% and TXMD returned +51.2%; their daily moves had a correlation of 0.05.
ATOS −83.0% TXMD +51.2%Growth of $1, one year, split-adjusted
| Metric | ATOS | TXMD |
|---|---|---|
| Price | $2.23 | $1.83 |
| Market cap | $22.3M | $21.2M |
| Today | −5.91% | +2.23% |
| 1 month | +14.4% | −9.9% |
| 6 months | −58.5% | −10.3% |
| Year to date | −74.8% | +12.3% |
| 1 year | −84.1% | +46.4% |
| Revenue growth (YoY) | — | −8.7% |
| Gross margin | — | 100.0% |
| Net margin | — | 17.8% |
| P/E (TTM) | — | — |
| Price / sales | — | 6.5× |
| Net cash | $26.1M | $9.2M |
| Dividend yield | — | — |
| Volatility (60d) | 75.6% | 33.7% |
| Short % of float | 7.7% | 0.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).